Fragmentation in US health care delivery streams and shortcomings in formal quality measures mean that transparency could be more useful to policymakers and regulators than patients.
AMA J Ethics. 2022;24(11):E1075-1082. doi:
10.1001/amajethics.2022.1075.
Sarosh Nagar, Leah Z. Rand, PhD, and Aaron S. Kesselheim, MD, JD, MPH
This article analyzes differences in prescription drug pricing transparency practices among 3 Organisation of Economic Co-operation and Development member nations.
AMA J Ethics. 2022;24(11):E1083-1090. doi:
10.1001/amajethics.2022.1083.
Megan Chao Smith joins Ethics Talk to discuss their article, coauthored with Dr Shanda Demorest: “How Should Clinicians and Health Care Organizations Respond When Civic Planning Concentrates Waste Processing in Minoritized Communities?”
Ariel Levchenko joins Ethics Talk to discuss his article, coauthored with Scott Schweikart: “How Should Regulations Help Health Care Organizations Manage Waste?”
Dr Amy Collins joins Ethics Talk to discuss her article, coauthored with Dr Shanda Demorest: “How Should We Respond to Health Care Generating Environmental Harm?”
Ava Ferguson Bryan, MD, AM, Elizabeth Yates, MD, MPH, and Neelima Tummala, MD, MSc
The health sector has obligations and ample opportunities to protect health by decreasing waste and motivating more system-wide sustainable clinical practices.
AMA J Ethics. 2022;24(10):E927-933. doi:
10.1001/amajethics.2022.927.